Kate F. Whitecross
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Regulation of Appetite and Obesity, T-cell and Retrovirus Studies, Nuclear Receptors and Signaling
Most-Cited Works
- → Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma(2007)198 cited
- → Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors(2008)80 cited
- → Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin(2008)67 cited
- → Src Homology 3-Domain Growth Factor Receptor-Bound 2-Like (Endophilin) Interacting Protein 1, a Novel Neuronal Protein that Regulates Energy Balance(2005)50 cited
- → Genetic Variation and Obesity in Australian Women: A Prospective Study(2001)25 cited
- → Elevated hypothalamic beacon gene expression in Psammomys obesus prone to develop obesity and type 2 diabetes(2002)23 cited
- → P51. Defining the apoptotic pathways underlying histone deacetylase inhibitor-mediated tumor therapy(2006)
- The tumour necrosis factor-alpha-308 promoter polymorphism is associated with increased insulin sensitivity in Caucasian Australian females.(1999)
- → Supplementary Table S1 from Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin(2023)
- Characterization of the apoptotic and therapeutic activities of the histone deacetylase inhibitors LAQ824 and LBH589 using a mouse model of B cell lymphoma.(2007)